全文获取类型
收费全文 | 814篇 |
免费 | 65篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 26篇 |
妇产科学 | 5篇 |
基础医学 | 112篇 |
口腔科学 | 81篇 |
临床医学 | 66篇 |
内科学 | 179篇 |
皮肤病学 | 14篇 |
神经病学 | 50篇 |
特种医学 | 39篇 |
外科学 | 100篇 |
综合类 | 28篇 |
预防医学 | 29篇 |
眼科学 | 70篇 |
药学 | 34篇 |
中国医学 | 5篇 |
肿瘤学 | 65篇 |
出版年
2023年 | 1篇 |
2022年 | 6篇 |
2021年 | 18篇 |
2020年 | 16篇 |
2019年 | 14篇 |
2018年 | 19篇 |
2017年 | 21篇 |
2016年 | 25篇 |
2015年 | 31篇 |
2014年 | 30篇 |
2013年 | 49篇 |
2012年 | 31篇 |
2011年 | 39篇 |
2010年 | 40篇 |
2009年 | 30篇 |
2008年 | 47篇 |
2007年 | 52篇 |
2006年 | 45篇 |
2005年 | 44篇 |
2004年 | 27篇 |
2003年 | 36篇 |
2002年 | 31篇 |
2001年 | 22篇 |
2000年 | 10篇 |
1999年 | 21篇 |
1998年 | 25篇 |
1997年 | 26篇 |
1996年 | 19篇 |
1995年 | 18篇 |
1994年 | 17篇 |
1993年 | 8篇 |
1992年 | 9篇 |
1991年 | 11篇 |
1990年 | 8篇 |
1989年 | 10篇 |
1988年 | 5篇 |
1987年 | 6篇 |
1986年 | 14篇 |
1985年 | 5篇 |
1984年 | 2篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1975年 | 3篇 |
1972年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有914条查询结果,搜索用时 15 毫秒
1.
Vincent Chung Liang Liu Zhaoxiang Bian Zhongzhen Zhao Wai Leuk Fong Wan Fung Kum Jing Gao Min Li 《Movement disorders》2006,21(10):1709-1715
The objective of this study is to assess the efficacy and safety of herbal medicines (HMs), as a monotherapy or adjunct therapy, compared to placebo or conventional approaches in the treatment of idiopathic Parkinson's disease (PD). We conducted a systematic review of randomized controlled trials from both conventional and alternative medicine sources. Outcome measures were overall improvement, quality of life, reduction of levodopa dose, and adverse events. Nine studies were included, each testing a different HM. Six of the trials had limited internal validity due to major flaws in design, including the lack of proper randomization; insufficient blinding; unclear inclusive criteria in terms of diagnostic criteria, baseline staging, and duration of disease; lack of proper sample size calculation; and insufficient data analysis. Imbalances in gender and ethnicity among the patients in the included trials were observed. No major adverse events emerged, and no specific pattern was detected from the trials describing such data. In addition to major methodological defects, heterogeneity in (1) HM tested, (2) control treatment, and (3) outcome measure hindered in-depth data analysis and synthesis. Current evidence is insufficient to evaluate the efficacy and safety of various HMs. Further studies with improved trial design and reporting, with assessment on cost-effectiveness, quality of life, and qualitative data are warranted. 相似文献
2.
3.
4.
5.
6.
7.
8.
Recombinant VP9-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Banna virus (genus Seadornavirus) 总被引:1,自引:0,他引:1
Mohd Jaafar F Attoui H Gallian P Isahak I Wong KT Cheong SK Nadarajah VS Cantaloube JF Biagini P De Micco P De Lamballerie X 《Journal of virological methods》2004,116(1):55-61
Banna virus (BAV, genus Seadornavirus, family Reoviridae) is an arbovirus suspected to be responsible for encephalitis in humans. Two genotypes of this virus are distinguishable: A (Chinese isolate, BAV-Ch) and B (Indonesian isolate, BAV-In6969) which exhibit only 41% amino-acid identity in the sequence of their VP9.The VP7 to VP12 of BAV-Ch and VP9 of BAV-In6969 were expressed in bacteria using pGEX-4T-2 vector. VP9 was chosen to establish an ELISA for BAV, based mainly on two observations: (i). VP9 is a major protein in virus-infected cells and is a capsid protein (ii). among all the proteins expressed, VP9 was obtained in high amount and showed the highest immuno-reactivity to anti-BAV ascitic fluid.The VP9s ELISA was evaluated in three populations: French blood donors and two populations (blood donors and patients with a neurological syndrome) from Malaysia, representing the region where the virus was isolated in the past.The specificity of this ELISA was >98%. In mice injected with live BAV, the assay detected IgG-antibody to BAV infection 21 days post-injection, which was confirmed by Western blot using BAV-infected cells.The VP9 ELISA permits to determine the sero-status of a population without special safety precautions and without any requirements to propagate the BAV. This test should be a useful tool for epidemiological survey of BAV. 相似文献
9.
doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH) 总被引:12,自引:0,他引:12
des Portes V; Francis F; Pinard JM; Desguerre I; Moutard ML; Snoeck I; Meiners LC; Capron F; Cusmai R; Ricci S; Motte J; Echenne B; Ponsot G; Dulac O; Chelly J; Beldjord C 《Human molecular genetics》1998,7(7):1063-1070
Subcortical laminar heterotopia (SCLH), or 'double cortex', is a cortical
dysgenesis disorder associated with a defect in neuronal migration.
Clinical manifestations are epilepsy and mental retardation. This disorder,
which mainly affects females, can be inherited in a single pedigree with
lissencephaly, a more severe disease which affects the male individuals.
This clinical entity has been described as X- SCLH/LIS syndrome. Recently
we have demonstrated that the doublecortin gene, which is localized on the
X chromosome, is implicated in this disorder. We have now performed a
systematic mutation analysis of doublecortin in 11 unrelated females with
SCLH (one familial and 10 sporadic cases) and have identified mutations in
10/11 cases. The sequence differences include nonsense, splice site and
missense mutations and these were found throughout the gene. These results
provide strong evidence that loss of function of doublecortin is the major
cause of SCLH. The absence of phenotype-genotype correlations suggests that
X-inactivation patterns of neuronal precursor cells are likely to
contribute to the variable clinical severity of this disorder in females.
相似文献